Skip to content

Clinical trials

Terminated Pulmonary Arterial Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Terminated Country / region: United States Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20063
20071
20085
20092
20105
20115
20121
20134
20141
20152
20166
20172
20184
20195
20215
20224
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated59

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion7
Novartis Pharmaceuticals7
Pfizer4
United Therapeutics4
Aerovate Therapeutics2
Aires Pharmaceuticals, Inc.2
Biogen2
Complexa, Inc.2
Idorsia Pharmaceuticals Ltd.2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension59
Hypertension, Pulmonary28
Familial Primary Pulmonary Hypertension4
Hypertension4
Cardiovascular Diseases3
Lung Diseases3
Vascular Diseases3
Connective Tissue Diseases2
Cough2
Dizziness2

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.